Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Norwich
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Norwich, CT

Studies commonly pay $75 to $4,500 per completed study

121 clinical trials are currently recruiting participants within 30 miles of Norwich. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

121studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Norwich right now

Top 25 of 121 recruiting studies, sorted by proximity — each links to its official registry page

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: Abramson Cancer Center at Penn Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06551116)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retina Group of New England — Waterford, Connecticut (14.6 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought
Clinical Research Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07398417)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Problems Related to Social Environment N/A Interventional 318 participants sought
University of Connecticut — Storrs, Connecticut (19.7 mi) · Sponsor: NYU Langone Health
See eligibility & contact on ClinicalTrials.gov (NCT05675735)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Hartford HealthCare - Manchester — Manchester, Connecticut (27.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

Periodontitis (Stage 3) N/A Interventional 72 participants sought
Shoreline Periodontics and Dental Implants — New London, Connecticut (13.4 mi) · Sponsor: McGuire Institute
See eligibility & contact on ClinicalTrials.gov (NCT06914596)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retina Group of New England, PC — Waterford, Connecticut (14.6 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 165 — Waterford, Connecticut (14.6 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Dyslipidemias, Obesity EARLY/Phase 1 Interventional 130 participants sought
University of Connecticut — Storrs, Connecticut (19.7 mi) · Sponsor: University of Connecticut
See eligibility & contact on ClinicalTrials.gov (NCT05700916)

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder Phase 3 Interventional 850 participants sought
Neurocrine Clinical Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT06966401)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04402788)

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Metastatic Urothelial Cancer Phase 2 Interventional 827 participants sought
Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut (1.9 mi) · Sponsor: Gilead Sciences
See eligibility & contact on ClinicalTrials.gov (NCT03547973)

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04804644)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Plaque Psoriasis Phase 2 Interventional 240 participants sought
Oruka Therapeutics Investigative Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Oruka Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07449702)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)
Google-rated

Top-rated research centers in Norwich

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Comprehensive Research Center

200 W Town St, Norwich, CT 06360
(860) 886-1508 ext. 23

Eastern Connecticut Hematology and Oncology

★ 4.7 (215 reviews)
Medical Office Building, 330 Washington St STE 220, Norwich, CT 06360
(860) 886-8362
"It was a good visit informational and understood all that was told to me"
— Milton Poppie, 4★

Coastal Connecticut Research

★ 5.0
342 Montauk Ave, New London, CT 06320
(860) 437-7092
"Clinical trials and research studies for multiple sclerosis, alzheimer's, overactive bladder, hot flashes, and birth control, Friendly, caring, kn…"
— Sindi Mannochi, 5★

ECHO Cancer Foundation

★ 5.0
330 Washington St, Norwich, CT 06360
(860) 460-9722

CT Clinical Research

160 West St Ste 1A, Cromwell, CT 06416
(860) 632-0144

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Clinical Trials of New England

1234 Hyde Park Ave #205, Hyde Park, MA 02136

Clinical Trials

100 Retreat Ave, Hartford, CT 06106
(860) 244-0148

Clinical Research Consulting LLC

★ 4.0
2080 Bridgeport Ave D, Milford, CT 06460
(203) 386-3115
"Just finishing up a research study with them, they are all very friendly and organized. They are efficient and do a good job of getting you in and ou…"
— Stephen Callahan, 5★

Clinical trials in Norwich: what's recruiting

The Norwich area currently has 121 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Norwich, the most active research areas are:

  • Cancer & Oncology15 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Norwich, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Norwich

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Norwich participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Norwich?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Norwich safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Norwich, CT?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Norwich?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Norwich.

Paid clinical trials near Norwich

Other metros within reach

Hartford, CT445 Providence, RI551 Springfield, MA325 Worcester, MA270 New Haven, CT1,187 Waterbury, CT1,146 New Bedford, MA514 Bridgeport, CT1,460

More of CT

Bridgeport1,460 New Haven1,187 Danbury1,164 Waterbury1,146 Hartford445

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts